Development of specific growth charts for children with Fanconi anemia.

Fanconi anemia LMS method delayed growth disease-specific chart growth hematopoietic cell transplant

Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
05 Feb 2024
Historique:
revised: 21 12 2023
received: 15 09 2023
accepted: 20 01 2024
medline: 6 2 2024
pubmed: 6 2 2024
entrez: 6 2 2024
Statut: aheadofprint

Résumé

Patients with Fanconi anemia (FA) are often perceived to have poor growth when general population growth curves are utilized. We hypothesize that FA patients have unique growth and aimed to create FA-specific growth charts. Height and weight data from ages 0 to 20 years were extracted from medical records of patients treated at the Fanconi Anemia Comprehensive Care Clinic at the University of Minnesota. Height, weight, and BMI growth curves were generated and fitted to reference percentiles using the Lambda-Mu-Sigma method. FA-specific percentiles were compared to WHO standards for ages 0-2 and CDC references for ages 2-20. In FA males, the 50th height- and weight-for-age percentiles overlap with the 3rd reference percentile. In FA females, only the 50th height-for-age percentile overlaps with the 3rd reference percentile. For weight, FA females show progressive growth failure between 6 and 24 months followed by stabilization around the 50th percentile. The FA BMI-for-age percentiles show similar patterns to the weight-for-age percentiles but have different timing of onset of adiposity rebound and broader variability in females. Growth in FA patients follows a different trajectory than available normative curves. FA-specific growth charts may be useful to better guide accurate growth expectations, evaluations, and treatment.

Identifiants

pubmed: 38317562
doi: 10.1002/ajmg.a.63554
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Kidz1stFund

Informations de copyright

© 2024 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Auerbach, A. D. (2009). Fanconi anemia and its diagnosis. Mutation Research, 668(1-2), 4-10. https://doi.org/10.1016/j.mrfmmm.2009.01.013
Barnum, J. L., Petryk, A., Zhang, L., DeFor, T. E., Baker, K. S., Steinberger, J., Nathan, B., Wagner, J. E., & MacMillan, M. L. (2016). Endocrinopathies, bone health, and insulin resistance in patients with Fanconi anemia after hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 22(8), 1487-1492. https://doi.org/10.1016/j.bbmt.2016.05.004
Bhandari, J., Thada, P., & Puckett, Y. (2022). Fanconi Anemia. StatPearls Publishing.
Cole, T. J., & Green, P. J. (1992). Smoothing reference centile curves: The LMS method and penalized likelihood. Statistics in Medicine, 11(10), 1305-1319. https://doi.org/10.1002/sim.4780111005
Daymont, C., Ross, M. E., Russell Localio, A., Fiks, A. G., Wasserman, R. C., & Grundmeier, R. W. (2017). Automated identification of implausible values in growth data from pediatric electronic health records. Journal of the American Medical Informatics Association, 24(6), 1080-1087. https://doi.org/10.1093/jamia/ocx037
Forlenza, G. P., Polgreen, L. E., Miller, B. S., MacMillan, M. L., Wagner, J. E., & Petryk, A. (2014). Growth hormone treatment of patients with Fanconi anemia after hematopoietic cell transplantation. Pediatric Blood & Cancer, 61(6), 1142-1143. https://doi.org/10.1002/pbc.24910
Giri, N., Batista, D. L., Alter, B. P., & Stratakis, C. A. (2007). Endocrine abnormalities in patients with Fanconi anemia. The Journal of Clinical Endocrinology and Metabolism, 92(7), 2624-2631. https://doi.org/10.1210/jc.2007-0135
Glanz, A., & Fraser, F. C. (1982). Spectrum of anomalies in Fanconi anaemia. Journal of Medical Genetics, 19, 412-416. https://doi.org/10.1136/jmg.19.6.412
Isojima, T., Sakazume, S., Hasegawa, T., Ogata, T., Nakanishi, T., Nagai, T., & Yokoya, S. (2016). Growth references for Japanese individuals with Noonan syndrome. Pediatric Research, 79(4), 543-548. https://doi.org/10.1038/pr.2015.254
Johnson-Tesch, B. A., Gawande, R. S., Zhang, L., MacMillan, M. L., & Nascene, D. R. (2017). Fanconi anemia: Correlating central nervous system malformations and genetic complementation groups. Pediatric Radiology, 47(7), 868-876. https://doi.org/10.1007/s00247-017-3817-x
Malaquias, A. C., Brasil, A. S., Pereira, A. C., Arnhold, I. J., Mendonca, B. B., Bertola, D. R., & Jorge, A. A. (2012). Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS/MAPK pathway. American Journal of Medical Genetics. Part A, 158A(11), 2700-2706. https://doi.org/10.1002/ajmg.a.35519
Martin, N. D., Smith, W. R., Cole, T. J., & Preece, M. A. (2007). New height, weight and head circumference charts for British children with Williams syndrome. Archives of Disease in Childhood, 92(7), 598-601. https://doi.org/10.1136/adc.2006.107946
McReynolds, L. J., Wang, Y., Thompson, A. S., Ballew, B. J., Kim, J., Alter, B. P., Hicks, B., Zhu, B., Jones, K., Spellman, S. R., Wang, T., Lee, S. J., Savage, S. A., & Gadalla, S. M. (2020). Population frequency of Fanconi pathway gene variants and their association with survival after hematopoietic cell transplantation for severe aplastic anemia. Biology of Blood and Marrow Transplantation, 26(5), 817-822. https://doi.org/10.1016/j.bbmt.2020.01.011
Mehta, P., & Ebens, C. (Eds.). (2021). Fanconi anemia. GeneReviews® [Internet].
Nagai, T., Matsuo, N., Kayanuma, Y., Tonoki, H., Fukushima, Y., Ohashi, H., Murai, T., Hasegawa, T., Kuroki, Y., & Niikawa, N. (2000). Standard growth curves for Japanese patients with Prader-Willi syndrome. American Journal of Medical Genetics, 95(2), 130-134. https://doi.org/10.1002/1096-8628(20001113)95:2<130::aid-ajmg7>3.0.co;2-r
Petryk, A., Kanakatti Shankar, R., Giri, N., Hollenberg, A. N., Rutter, M. M., Nathan, B., Lodish, M., Alter, B. P., Stratakis, C. A., & Rose, S. R. (2015). Endocrine disorders in Fanconi anemia: Recommendations for screening and treatment. The Journal of Clinical Endocrinology and Metabolism, 100(3), 803-811. https://doi.org/10.1210/jc.2014-4357
Rigby, R. A., & Stasinopoulos, D. M. (2004). Smooth centile curves for skew and kurtotic data modelled using the box-cox power exponential distribution. Statistics in Medicine, 23(19), 3053-3076. https://doi.org/10.1002/sim.1861
Rose, S. R., Myers, K. C., Rutter, M. M., Mueller, R., Khoury, J. C., Mehta, P. A., Harris, R. E., & Davies, S. M. (2012). Endocrine phenotype of children and adults with Fanconi anemia. Pediatric Blood & Cancer, 59(4), 690-696. https://doi.org/10.1002/pbc.24095
Silva, P., Schmit, D., Bonfim, C., Campos, D. J., Rabito, E. I., & Vilela, R. M. (2017). Body composition of Fanconi anemia patients after hematopoietic stem cell transplantation. Revista Brasileira de Hematologia e Hemoterapia, 39(4), 318-324. https://doi.org/10.1016/j.bjhh.2017.06.004
Soulier, J. (2011). Fanconi Anemia. Hematology. American Society of Hematology. Education Program, 1, 492-497. https://doi.org/10.1182/asheducation-2011.1.492
Styles, M., Cole, T., Dennis, J., & Preece, M. (2002). New cross sectional stature, weight, and head circumference references for Down's syndrome in the UK and Republic of Ireland. Archives of Disease in Childhood, 87, 104-108. https://doi.org/10.1136/adc.87.2.104
Wajnrajch, M. P., Gertner, J. M., Huma, Z., Popovic, J., Lin, K., Verlander, P. C., Batish, S. D., Giampietro, P. F., Davis, J. G., New, M. I., & Auerbach, A. D. (2001). Evaluation of growth and hormonal status in patients referred to the international Fanconi anemia registry. Pediatrics, 107(4), 744-754. https://doi.org/10.1542/peds.107.4.744
Witt, D. R., Keena, B. A., Hall, J. G., & Allanson, J. E. (1986). Growth curves for height in Noonan syndrome. Clinical Genetics, 30(3), 150-153. https://doi.org/10.1038/pr.2015.254

Auteurs

Crystal Barbus (C)

Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School and M Health Fairview Masonic Children's Hospital, Minneapolis, Minnesota, USA.

Arpana Rayannavar (A)

Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School and M Health Fairview Masonic Children's Hospital, Minneapolis, Minnesota, USA.

Bradley S Miller (BS)

Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School and M Health Fairview Masonic Children's Hospital, Minneapolis, Minnesota, USA.

Mica J Jenkins (MJ)

Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Nutrition and Health Sciences Doctoral Program, Laney Graduate School of Emory University, Atlanta, Georgia, USA.

O Yaw Addo (OY)

Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Nutrition and Health Sciences Doctoral Program, Laney Graduate School of Emory University, Atlanta, Georgia, USA.

Ahmad Rayes (A)

Nutrition and Health Sciences Doctoral Program, Laney Graduate School of Emory University, Atlanta, Georgia, USA.

Natasha Ahrweiler (N)

Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School and M Health Fairview Masonic Children's Hospital, Minneapolis, Minnesota, USA.

Alisha Olson (A)

Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School and M Health Fairview Masonic Children's Hospital, Minneapolis, Minnesota, USA.

Zachary Pohlkamp (Z)

Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School and M Health Fairview Masonic Children's Hospital, Minneapolis, Minnesota, USA.

John E Wagner (JE)

Division of Blood and Marrow Transplantation & Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.

Margaret L MacMillan (ML)

Division of Blood and Marrow Transplantation & Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.

Classifications MeSH